Principal Financial Group Inc. Boosts Stake in The Cooper Companies, Inc. $COO

Principal Financial Group Inc. grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 5.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 231,151 shares of the medical device company’s stock after acquiring an additional 11,774 shares during the period. Principal Financial Group Inc.’s holdings in Cooper Companies were worth $16,527,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. DAVENPORT & Co LLC increased its stake in shares of Cooper Companies by 1,359.7% in the fourth quarter. DAVENPORT & Co LLC now owns 567,203 shares of the medical device company’s stock worth $46,642,000 after buying an additional 528,346 shares during the last quarter. Fluent Financial LLC acquired a new stake in Cooper Companies in the fourth quarter valued at $3,517,000. Heartland Advisors Inc. bought a new position in Cooper Companies during the 4th quarter valued at $15,348,000. Wealth Enhancement Advisory Services LLC boosted its stake in Cooper Companies by 212.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 31,455 shares of the medical device company’s stock valued at $2,652,000 after acquiring an additional 21,383 shares during the last quarter. Finally, Assetmark Inc. grew its holdings in Cooper Companies by 21.0% during the 4th quarter. Assetmark Inc. now owns 184,410 shares of the medical device company’s stock worth $15,114,000 after acquiring an additional 31,980 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Down 0.7%

Cooper Companies stock opened at $70.50 on Thursday. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The firm’s 50-day moving average is $66.93 and its 200-day moving average is $72.28. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27. The company has a market cap of $13.75 billion, a P/E ratio of 59.75, a PEG ratio of 1.86 and a beta of 0.84.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on COO. Robert W. Baird dropped their target price on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a research report on Friday, June 5th. JPMorgan Chase & Co. decreased their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. The Goldman Sachs Group set a $61.00 price objective on Cooper Companies in a report on Wednesday, May 27th. Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Finally, Piper Sandler set a $86.00 target price on Cooper Companies and gave the stock an “overweight” rating in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $81.85.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.